CHUTimone

Marseille 13385

1 studies enrolling now · 5 studies all time

What they study most

Advanced Cancer, Bone Cancer, Breast Cancer, Colorectal Cancer, Congenital Myasthenic Syndrome, Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer, Metastatic Melanoma, Metastatic Tumours, Neoplasms, Non-small Cell Lung Cancer (NSCLC), Non-small Cell Lung Carcinoma

Studies at this site

• A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4 — Recruiting now
• DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer — Running, not enrolling
• A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors — Completed
• Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. — Stopped early
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed